Transforming Growth Factor Beta 1 (TGFb1)

TGF-B1; CED; DPD1; LAP; Camurati-Engelmann Disease; Latency-associated peptide

Transforming Growth Factor Beta 1 (TGFb1)

TGF-β is capable of producing a variety of effects and virtually all cell types respond to this factor in some way. The inappropriate presence of active TGF-β1 has been implicated in a variety of pathological conditions Because of the necessity for regulating its activity tightly, TGF-β is secreted by cells in the form of an inactive complex. This complex consists of TGF-β1 associated non-covalently with a protein designated the latency associated peptide (LAP).

TGF-β1 and LAP represent components of a pro-peptide that is cleaved in a post-golgi compartment prior to secretion. LAP and TGF-β1 each consist of a disulfide-linked homodimer and the association of these two components renders TGF-β1 inactive and inaccessible to anti-TGF-β antibodies.

Organism species: Homo sapiens (Human)

Organism species: Mus musculus (Mouse)

Organism species: Rattus norvegicus (Rat)

Organism species: Cavia (Guinea pig )

Organism species: Oryctolagus cuniculus (Rabbit)

Organism species: Rhesus monkey (Simian)

Organism species: Canis familiaris; Canine (Dog)

Organism species: Sus scrofa; Porcine (Pig)

Organism species: Bos taurus; Bovine (Cattle)

Organism species: Capra hircus; Caprine (Goat)

Organism species: Ovis aries; Ovine (Sheep)

Organism species: Equus caballus; Equine (Horse)

Organism species: Chicken (Gallus)

Organism species: Danio rerio (Zebrafish)